TITAN PHARMACEUTICALS INC. news, videos and press releases
For more news please use our advanced search feature.
TITAN PHARMACEUTICALS INC. - More news...
TITAN PHARMACEUTICALS INC. - More news...
- SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Titan Pharmaceuticals, Inc. - TTNP
- Shareholder Alert: Ademi LLP investigates whether Titan Pharmaceuticals, Inc. has obtained a Fair Price for its Public Shareholders
- Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.
- Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
- Titan Pharmaceuticals Announces Reverse Stock Split and Ratio
- Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors
- Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock
- Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets
- Titan Pharmaceuticals Provides Shareholder Update
- Titan Pharmaceuticals Announces Board Expansion and Management Changes
- Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant
- Titan Pharmaceuticals Announces Pricing of $5.5 Million Registered Direct and PIPE Offering Priced At-The-Market
- Titan Pharmaceuticals to Explore Strategic Alternatives
- Sustained Anti-Pruritic Effect Of Titan's TP-2021 Implant Reported Today At Neuroscience 2021
- Titan Announces Upcoming TP-2021 Implant Data Presentation at Neuroscience 2021
- Titan Pharmaceuticals Receives Funding to Develop Combination HIV Therapeutic and Contraceptive Implant for Women in Developing Countries
- Titan Pharmaceuticals and MUSC FRD Enter Into Research and Option License Agreement
- Titan Pharmaceuticals Announces Filing Of 2020 Annual Report On Form 10-K
-
Titan Pharmaceuticals, Inc. - TTNP Stock Chart Technical Analysis for 02-18-2021
- Positive Early Study Results Help Pave Wave for Titan Pharmaceuticals to Move Forward with its JT-09 ProNeura® Development Program
- Titan Pharmaceuticals Announces Pricing of $9.7 Million Registered Direct Offering
- Titan Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
-
Titan Pharmaceuticals, Inc. - TTNP Stock Chart Technical Analysis for 12-01-2020
-
Titan Pharmaceuticals, Inc. - TTNP Stock Chart Technical Analysis for 11-30-2020
- Titan Pharmaceuticals Announces Reverse Stock Split
-
Titan Pharmaceuticals, Inc. - TTNP Stock Chart Technical Analysis for 11-27-2020
-
Titan Pharmaceuticals, Inc. - TTNP Stock Chart Technical Analysis for 11-25-2020
-
Titan Pharmaceuticals, Inc. - TTNP Stock Chart Technical Analysis for 11-23-2020
- Thinking about buying stock in Nio, Titan Pharmaceuticals, Zomedica Corp, Gevo Inc, or Transocean?
-
Titan Pharmaceuticals, Inc. - TTNP Stock Chart Technical Analysis for 11-20-2020
